3 Cannabis Stocks For The Budding Rebound

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
3 Cannabis Stocks For The Budding ReboundThe Cannabis Market Is Reversing

 With the Alternative Harvest ETF (NYSEARCA:MJ) up more than 50% from its lows it is beginning to look like a major reversal is underway in the cannabis market. Not only are overcapacity and oversupply issues coming into alignment, but the Canadian cannabis producers are also in the best shape they’ve been in since pre-legalization. Add in the fact that Canada’s addressable market is slowly growing, and that expansion into the U.S. is closer than ever, and the stage is set for a multi-year rally in this market. But I wouldn’t buy the Alternative Harvest ETF, I’d buy these instead.

Canopy Growth Corporation Is The Biggest, And Best

Canopy Growth Corporation (NASDAQ:CGC) is Canada’s largest cannabis producer by revenue with operations in Canada, the U.S., and internationally. It is also the single largest holding of the Alternative Harvest ETF so you get a lot of the same exposure anyway. And more concentrated into the industry’s largest and most successful operator.

3 Cannabis Stocks For The Budding Rebound<

Two of Canopy Growth Corporation’s most recent moves are a partnership with Martha Stewart and the purchase of Sweetwater Brewing Company. The deal with Martha Stewart expands the company’s reach into the U.S. with branded CBD products. The Sweetwater deal further expands the company’s reach into the U.S. and its capacity to produce infused beverages.


Over the past two quarters, Canopy Growth Corporation’s metrics have improved along with revenue growth. The company has been trimming excesses within the operation and clearing up the balance sheet with the goal of profitability in mind. Based on the most recent report it looks like the company could deliver positive EBITDA margins in mid to late calendar 2021 and a full year ahead of schedule.

Cresco Labs For U.S. Exposure

While Canopy Growth Corporation and other Canadian producers prepare for the passing of Federal legalization in the U.S., Cresco Labs (OTCMKTS:CRLBF) is quietly building an empire in the U.S. Cresco Labs is a Chicago-based U.S. multi-state operator. The company has production, processing, and dispensaries in 8 states including the U.S. largest market, California. Over the course of the past two quarters, this company has not only improved its operations via leveraging capacity, organic growth, and expanding footprint but it has turned a profit. That’s right, a cannabis company that makes money.

“Cresco Labs entered the third quarter firing on all cylinders achieving record levels of revenue, profitability, and cash flow. We remain the number one operator in the industry focused on, and delivering results in, the wholesale distribution of branded products. Our retail is outperforming, and we are generating substantial operating leverage,” said Charles Bachtell, Co-founder and CEO of Cresco Labs.

Innovative Industrial Properties, Cannabis Exposure, And A Dividend

Innovative Industrial Properties (NYSE:IIPR) came on to my radar one day while screening for REITs and I am glad it did. The company is a real estate investment trust with a pure focus on the cannabis industry. Operations include the purchase and leaseback of cannabis facilities primarily on a triple-net basis. That means IIPR owns the buildings, makes money from rents, and pays nearly none of the costs of maintenance, licensing, or improvements. The benefit to the cannabis industry is a means of raising capital in a non-dilutive manner while preserving operations. The benefit for investors is cannabis exposure, a safety net in the form of property ownership (the cannabis company may go bankrupt but the property is forever), and a dividend. At today’s prices, the stock is yielding about 3.0% with an expectation for future growth.

3 Cannabis Stocks For The Budding Rebound
→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Canopy Growth right now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Canopy Growth (CGC)
0.8295 of 5 stars
$7.85-1.0%N/A-0.52Reduce$4.87
Compare These Stocks  Add These Stocks to My Watchlist 

Thomas Hughes

About Thomas Hughes

  • tmhughes.writeon@gmail.com

Contributing Author

Technical and Fundamental Analysis

Experience

Thomas Hughes has been a contributing writer for MarketBeat since 2019.

Areas of Expertise

Technical analysis, the S&P 500; retail, consumer, consumer staples, dividends, high-yield, small caps, technology, economic data, oil, cryptocurrencies

Education

Associate of Arts in Culinary Technology

Past Experience

Market watcher, trader and investor for numerous websites. Founded Passive Market Intelligence LLC to provide market research insights. 


Featured Articles and Offers

Search Headlines: